Clinical observationon nab-paclitaxel plus platinum versus gemcitabine plus platinum as first-line treatment in patients with advanced lung squamous cell carcinoma

TANG Juanjuan; HAN Zhengxiang; LIU Wenlou; WANG Hongmei; ZHAO Yang; GE Yan; QIN Xiaobing

doi:10.3969/j.issn.1674-4136.2022.01.012

Home>Articles>Clinical observationon nab-paclitaxel plus platinum versus gemcitabine plus platinum as first-line treatment in patients with advanced lung squamous cell carcinoma

DOI: 10.3969/j.issn.1674-4136.2022.01.012

Clinical observationon nab-paclitaxel plus platinum versus gemcitabine plus platinum as first-line treatment in patients with advanced lung squamous cell carcinoma

TANG Juanjuan

HAN Zhengxiang

LIU Wenlou

WANG Hongmei

ZHAO Yang

GE Yan

QIN Xiaobing

Machine-generated Keywords：

Publication Date：2022-02-20

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 60-63,68 )

Chinese Journal of Surgical Oncology

ISTIC

ISSN：1674-4136

Year, Vol.(Issue)：2022,14(1)